1. López-Muñoz F, Alamo C, Rubio G, Cuenca E. Half a century since the clinical introduction of chlorpromazine and the birth of modern psychopharmacology. Prog Neuropsychopharmacol Biol Psychiatry 2004;28:205-208. PMID:
14756121.
2. López-Muñoz F, Alamo C, Cuenca E, Shen WW, Clervoy P, Rubio G. History of the discovery and clinical introduction of chlorpromazine. Ann Clin Psychiatry 2005;17:113-135. PMID:
16433053.
3. López-Muñoz F, Álamo C. The consolidation of neuroleptic therapy: Janssen, the discovery of haloperidol and its introduction into clinical practice. Brain Res Bull 2009;79:130-141. PMID:
19186209.
4. Shen WW. A history of antipsychotic drug development. Compr Psychiatry 1999;40:407-414. PMID:
10579370.
5. Kane J, Honigfeld G, Singer J, Meltzer H. Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Arch Gen Psychiatry 1988;45:789-796. PMID:
3046553.
6. Hippius H. A historical perspective of clozapine. J Clin Psychiatry 1999;60(Suppl 12):22-23. PMID:
10372606.
7. López-Muñoz F, Álamo C. Neurobiological background for the development of new drugs in schizophrenia. Clin Neuropharmacol 2011;34:111-126. PMID:
21586917.
8. Korean Neuropsychiatric Association. Annual Report 2011. 2011,Volume 27. Seoul: Korean Neuropsychiatric Association.
9. WHO and Ministry of Health and Welfare. WHO-AIMS Report on Mental Health System in Republic of Korea. 2007,Gwacheon: WHO.
10. Suh TW, Cho MJ, Kim JH, Kwak YS, Kim KK, Bae A, et al. 2005 The Central Mental Health Supporting Committee Report. 2006,Seoul: Ministry of Health and Welfare, Korean Institute for Health and Social Affairs, Central Mental Health Supporting Committee.
11. Hwang TY, Kim DH. Republic of Korea's Country Report. Asia-Pacific Community Mental Health Development Project. 2008,Melbourne: Asia Australia Mental Health (AAMH); p. 1-21.
12. Bordons M, Zulueta MA. Evaluation of the scientific activity through bibliometric indices. Rev Esp Cardiol 1999;52:790-800. PMID:
10563155.
13. White HD, McCain KW. Bibliometric. Ann Rev Inf Sci Technol 1989;24:119-186.
14. López-Muñoz F, Marín F, Boya J. Bibliometric evaluation of the Spanish scientific output in neurosciences. Analysis of the publication with international readership between 1984 and 1993. Rev Neurol 1996;24:417-426. PMID:
8721919.
15. López-Muñoz F, Alamo C, Rubio G, García-García P, Martín-Agueda B, Cuenca E. Bibliometric analysis of biomedical publications on SSRIs during the period 1980-2000. Depress Anxiety 2003;18:95-103. PMID:
12964177.
16. López-Muñoz F, Vieta E, Rubio G, García-García P, Alamo C. Bipolar disorder as an emerging pathology in the scientific literature: a bibliometric approach. J Affect Disord 2006;92:161-170. PMID:
16530847.
17. López-Muñoz F, Álamo C, Quintero-Gutiérrez FJ, García-García P. A bibliometric study of international scientific productivity in attention-deficit hyperactivity disorder covering the period 1980-2005. Eur Child Adolesc Psychiatry 2008;17:381-391. PMID:
18431538.
18. López-Muñoz F, García-García P, Sáiz-Ruiz J, Mezzich JE, Rubio G, Vieta E, et al. A bibliometric study of the use of the classification and diagnostic systems in psychiatry over the last 25 years. Psychopathology 2008;41:214-225. PMID:
18408417.
19. López-Muñoz F, Shen WW, Moreno R, Molina JD, Noriega C, Pérez-Nieto MA, et al. International scientific productivity on second-generation antipsychotic drugs in Taiwan: A bibliometric study. Taiwanese J Psychiatry 2012;26:114-129.
20. Price DJS. Little Science, Big Science. 1963,New York: Columbia University Press.
21. Bradford SC. Documentation. 1948,London: Crosby Lockwood.
22. Garfield E. Citation Indexing. Its Theory and Application in Science, Technology and Humanities. 1979,New York: Wiley.
23. Organization for Economic and Co-operative Development Health Division. OECD Health Data 2011 - Frequently Requested Data (June 30, 2011). 2011,Paris: OECD.
24. World Health Organization Department of Health Statistics and Informatics. World Health Statistics 2011 (May 13, 2011). 2011,Geneva: WHO.
25. Pritchard A. Statistical bibliography or bibliometrics. J Doc 1969;25:348-369.
26. Chong MY, Tan CH, Shinfuku N, Yang SY, Sim K, Fujii S, et al. Prescribing antipsychotic drugs for inpatients with schizophrenia in Asia: comparison of REAP-2001 and REAP-2004 studies. Asia-Pac Psychiatry 2010;2:77-84.
27. Nakano W, Yoshimura R, Yang S. The characteristics of pharmacotherapy for inpatients with schizophrenia: A multicentre comparative study in Asia. Eur Neuropsychopharmacol 2010;20(Suppl 3):S467-S468.
28. Shen WW. Clinical Psychopharmacology for the 21 Century. 2011,Third Edition. Taipei: Ho-Chi Publishing Company; (in Chinese).
29. Fountoulakis KN, Nimatoudis I, Iacovides A, Kaprinis G. Off-label indications for atypical antipsychotics: A systematic review. Ann Gen Hosp Psychiatry 2004;3:4PMID:
14975068.
30. Mortimer AM, Shepherd CJ, Rymer M, Burrows A. Primary care use of antipsychotic drugs: an audit and intervention study. Ann Gen Psychiatry 2005;4:18PMID:
16316473.
31. Xiang YT, Wang CY, Si TM, Lee EH, He YL, Ungvari GS, et al. Clozapine use in schizophrenia: findings of the Research on Asia Psychotropic Prescription (REAP) studies from 2001 to 2009. Aust N Z J Psychiatry 2011;45:968-975. PMID:
21888603.
32. Clement S, Singh S, Burns T. Status of bipolar disorder research. Bibliometric study. Br J Psychiatry 2003;182:148-152. PMID:
12562743.
33. Theander SS, Wetterberg L. Schizophrenia in Medline 1950-2006: a bibliometric investigation. Schizophr Res 2010;118:279-284. PMID:
19497712.
34. Johnson MH, Cohen J, Grudzinskas G. The uses and abuses of bibliometrics. Rep BioMed Online 2012;24:485-486.
35. Gómez I, Bordons M. Limitaciones en el uso de los indicadores bibliométricos para la evaluación científica. Política Científica 1996;46:21-26.
36. Molina JD, Jiménez-González AB, López-Muñoz F, Cañas F. Evolution of the concept of treatment-resistent schizophrneia: toward a reformulation for lack of an adequate response. J Exp Clin Med 2012;4:98-102.